These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Importance of ERK activation in As2O3-induced differentiation and promyelocytic leukemia nuclear bodies formation in neuroblastoma cells. Petit A; Delaune A; Falluel-Morel A; Goullé JP; Vannier JP; Dubus I; Vasse M Pharmacol Res; 2013 Nov; 77():11-21. PubMed ID: 24004656 [TBL] [Abstract][Full Text] [Related]
9. New retinoids and arsenic compounds for the treatment of refractory acute promyelocytic leukemia: clinical and basic studies for the next generation. Kitamura K; Kiyoi H; Yoshida H; Tobita T; Takeshita A; Ohno R; Naoe T Cancer Chemother Pharmacol; 1997; 40 Suppl():S36-41. PubMed ID: 9272132 [TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide as first-line treatment for acute promyelocytic leukemia. Leu L; Mohassel L Am J Health Syst Pharm; 2009 Nov; 66(21):1913-8. PubMed ID: 19850784 [TBL] [Abstract][Full Text] [Related]
11. Co-biomodulation with arsenic trioxide in multiple myeloma. Gallagher RE Leuk Res; 2001 Mar; 25(3):237-9. PubMed ID: 11226520 [No Abstract] [Full Text] [Related]
12. Arsenic trioxide: its role in acute promyelocytic leukemia and potential in other hematologic malignancies. Tallman MS Blood Rev; 2001 Sep; 15(3):133-42. PubMed ID: 11735161 [No Abstract] [Full Text] [Related]
13. Overcoming treatment resistance in acute promyelocytic leukemia and beyond. Fung TK; So CW Oncotarget; 2013 Aug; 4(8):1128-9. PubMed ID: 23934744 [No Abstract] [Full Text] [Related]
15. A novel differentiation-inducing therapy for acute promyelocytic leukemia with a combination of arsenic trioxide and GM-CSF. Muto A; Kizaki M; Kawamura C; Matsushita H; Fukuchi Y; Umezawa A; Yamada T; Hata J; Hozumi N; Yamato K; Ito M; Ueyama Y; Ikeda Y Leukemia; 2001 Aug; 15(8):1176-84. PubMed ID: 11480559 [TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide - An old drug rediscovered. Emadi A; Gore SD Blood Rev; 2010; 24(4-5):191-9. PubMed ID: 20471733 [TBL] [Abstract][Full Text] [Related]
17. Treatment of acute promyelocytic leukemia with arsenic trioxide. Tamm I; Paternostro G; Zapata JM N Engl J Med; 1999 Apr; 340(13):1043; author reply 1044-5. PubMed ID: 10189285 [No Abstract] [Full Text] [Related]
18. [Arsenic trioxide in the treatment of acute promyelocytic leukaemia]. Ercilla Liceaga M; Andueza Granados K; Fernández González I; Barcia Romero MJ Farm Hosp; 2003; 27(2):93-100. PubMed ID: 12717564 [TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide: acute promyelocytic leukemia and beyond. Bachleitner-Hofmann T; Kees M; Gisslinger H Leuk Lymphoma; 2002 Aug; 43(8):1535-40. PubMed ID: 12400595 [TBL] [Abstract][Full Text] [Related]
20. [Arsenic trioxide: impact on the growth and differentiation of cancer cells and possible use in cancer therapy]. Hoffman E; Mielicki WP Postepy Hig Med Dosw (Online); 2013 Aug; 67():817-27. PubMed ID: 24018447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]